E-LIB Suche - Ergebnisse für: Uyl-de Groot, Carin A

1

The Role of Medical Societies and the Relevance of Clinical..:

Julian, Elaine ; Solà-Morales, Oriol ; Garcia, Maria João...
Journal of Market Access & Health Policy. 12 (2024) 3 - p. 128-143 , 2024

Link: https://doi.org/10.3390/..

2

A health technology assessment of personalized nutrition in..:

Galekop, Milanne Maria Johanna ; del Bas, Josep Maria ; Calder, Philip C...
International Journal of Technology Assessment in Health Care. 40 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..

3

Assessing the clinical benefit of systemic anti-cancer trea..:

Leeneman, Brenda ; Xander, Nicolas S.H. ; Fiets, W. Edward...
European Journal of Cancer. 202 (2024) - p. 114002 , 2024

Link: https://doi.org/10.1016/..

4

New systemic treatment paradigms in resectable non-small ce..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe. 38 (2024) - p. 100840 , 2024

Link: https://doi.org/10.1016/..

5

Challenges and controversies in resectable non-small cell l..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe. 38 (2024) - p. 100841 , 2024

Link: https://doi.org/10.1016/..

6

Market entry agreements for innovative pharmaceuticals subj..:

Heine, Renaud J.S.D. ; Mathijssen, Ron H.J. ; Verbeek, Floor A.J...
Value in Health. , 2024

Link: https://doi.org/10.1016/..

7

Non-contrast short MRI surveillance for HCC screening: the ..:

van de Braak, Céline ; Willemssen, François E. J. A. ; de Man, Rob A....
European Radiology Experimental. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

8

Broadening the HTA of medical AI: A review of the literatur..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Visser, Jacob J...
Health Policy and Technology. 13 (2024) 2 - p. 100868 , 2024

Link: https://doi.org/10.1016/..

9

Results from Expanded Access Programs: A Review of Academic..:

Polak, Tobias B. ; Cucchi, David G. J. ; Schelhaas, Jasmin...
Drugs. 83 (2023) 9 - p. 795-805 , 2023

Link: https://doi.org/10.1007/..

10

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Pa..:

Jongbloed, Elisabeth M ; Blommestein, Hedwig M ; van Schoubroeck, Hannah M...
Breast Cancer: Targets and Therapy. 15 (2023) - p. 147-161 , 2023

Link: https://doi.org/10.2147/..

11

Economic Evaluation of a Personalized Nutrition Plan Based ..:

Galekop, Milanne Maria Johanna ; Uyl-de Groot, Carin ; Redekop, William Ken
PharmacoEconomics - Open. 8 (2023) 2 - p. 313-331 , 2023

Link: https://doi.org/10.1007/..

12

Prices of Orphan Drugs in Four Western European Countries B..:

Dane, Aniek ; Klein Gebbink, Anne-Sophie ; Brugma, Jan-Dietert...
Applied Health Economics and Health Policy. 21 (2023) 6 - p. 905-914 , 2023

Link: https://doi.org/10.1007/..

13

Cost-Effectiveness and Budget Impact of Future Developments..:

Simons, Martijn J.H.G. ; Uyl-de Groot, Carin A. ; Retèl, Valesca P....
Value in Health. 26 (2023) 1 - p. 71-80 , 2023

Link: https://doi.org/10.1016/..

14

Changes in survival in de novo metastatic cancer in an era ..:

Luyendijk, Marianne ; Visser, Otto ; Blommestein, Hedwig M...
JNCI: Journal of the National Cancer Institute. 115 (2023) 6 - p. 628-635 , 2023

Link: https://doi.org/10.1093/..

15

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly d..:

Chamuleau, Martine E D ; Stenner, Frank ; Chitu, Dana A...
The Lancet Haematology. 10 (2023) 12 - p. e966-e975 , 2023

Link: https://doi.org/10.1016/..